Literature DB >> 28708136

Differential requirements for Tousled-like kinases 1 and 2 in mammalian development.

Sandra Segura-Bayona1, Philip A Knobel1, Helena González-Burón1, Sameh A Youssef2,3, Aida Peña-Blanco1, Étienne Coyaud4,5, Teresa López-Rovira1, Katrin Rein1, Lluís Palenzuela1, Julien Colombelli1, Stephen Forrow1, Brian Raught4,5, Anja Groth6, Alain de Bruin2,7, Travis H Stracker1.   

Abstract

The regulation of chromatin structure is critical for a wide range of essential cellular processes. The Tousled-like kinases, TLK1 and TLK2, regulate ASF1, a histone H3/H4 chaperone, and likely other substrates, and their activity has been implicated in transcription, DNA replication, DNA repair, RNA interference, cell cycle progression, viral latency, chromosome segregation and mitosis. However, little is known about the functions of TLK activity in vivo or the relative functions of the highly similar TLK1 and TLK2 in any cell type. To begin to address this, we have generated Tlk1- and Tlk2-deficient mice. We found that while TLK1 was dispensable for murine viability, TLK2 loss led to late embryonic lethality because of placental failure. TLK2 was required for normal trophoblast differentiation and the phosphorylation of ASF1 was reduced in placentas lacking TLK2. Conditional bypass of the placental phenotype allowed the generation of apparently healthy Tlk2-deficient mice, while only the depletion of both TLK1 and TLK2 led to extensive genomic instability, indicating that both activities contribute to genome maintenance. Our data identifies a specific role for TLK2 in placental function during mammalian development and suggests that TLK1 and TLK2 have largely redundant roles in genome maintenance.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28708136      PMCID: PMC5635214          DOI: 10.1038/cdd.2017.108

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  53 in total

Review 1.  Genetic insights into trophoblast differentiation and placental morphogenesis.

Authors:  J C Cross
Journal:  Semin Cell Dev Biol       Date:  2000-04       Impact factor: 7.727

2.  Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity.

Authors:  Vibha Singh; Zachary M Connelly; Xinggui Shen; Arrigo De Benedetti
Journal:  Cell Cycle       Date:  2017-04-20       Impact factor: 4.534

3.  Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M Checkpoint.

Authors:  Jin-Ah Kim; Meenakshi Anurag; Jamunarani Veeraraghavan; Rachel Schiff; Kaiyi Li; Xiao-Song Wang
Journal:  Mol Cancer Res       Date:  2016-08-03       Impact factor: 5.852

4.  Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases.

Authors:  H H Silljé; E A Nigg
Journal:  Curr Biol       Date:  2001-07-10       Impact factor: 10.834

5.  TLK1B promotes repair of DSBs via its interaction with Rad9 and Asf1.

Authors:  Caroline Canfield; Justin Rains; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2009-12-20       Impact factor: 2.946

6.  Tousled kinase TLK1B mediates chromatin assembly in conjunction with Asf1 regardless of its kinase activity.

Authors:  Arrigo De Benedetti
Journal:  BMC Res Notes       Date:  2010-03-11

7.  Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.

Authors:  Darren R Krause; Jyoti C Jonnalagadda; Magtouf H Gatei; Herman H W Sillje; Bin-Bing Zhou; Erich A Nigg; Kumkum Khanna
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

8.  The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks.

Authors:  Gulshan Sunavala-Dossabhoy; Sri Kripa Balakrishnan; Siddhartha Sen; Sam Nuthalapaty; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2005-09-12       Impact factor: 2.946

9.  Expression Atlas update--an integrated database of gene and protein expression in humans, animals and plants.

Authors:  Robert Petryszak; Maria Keays; Y Amy Tang; Nuno A Fonseca; Elisabet Barrera; Tony Burdett; Anja Füllgrabe; Alfonso Muñoz-Pomer Fuentes; Simon Jupp; Satu Koskinen; Oliver Mannion; Laura Huerta; Karine Megy; Catherine Snow; Eleanor Williams; Mitra Barzine; Emma Hastings; Hendrik Weisser; James Wright; Pankaj Jaiswal; Wolfgang Huber; Jyoti Choudhary; Helen E Parkinson; Alvis Brazma
Journal:  Nucleic Acids Res       Date:  2015-10-19       Impact factor: 16.971

10.  Site-specific phosphorylation of the DNA damage response mediator rad9 by cyclin-dependent kinases regulates activation of checkpoint kinase 1.

Authors:  Carla Manuela Abreu; Ramesh Kumar; Danielle Hamilton; Andrew William Dawdy; Kevin Creavin; Sarah Eivers; Karen Finn; Jeremy Lynn Balsbaugh; Rosemary O'Connor; Patrick A Kiely; Jeffrey Shabanowitz; Donald F Hunt; Muriel Grenon; Noel Francis Lowndes
Journal:  PLoS Genet       Date:  2013-04-04       Impact factor: 5.917

View more
  10 in total

Review 1.  Preserving salivary gland physiology against genotoxic damage - the Tousled way.

Authors:  G Sunavala-Dossabhoy
Journal:  Oral Dis       Date:  2018-05-02       Impact factor: 3.511

2.  Using Human iPSC-Derived Neurons to Uncover Activity-Dependent Non-Coding RNAs.

Authors:  Mainá Bitar; Stefanie Kuiper; Elizabeth O'Brien; Guy Barry
Journal:  Genes (Basel)       Date:  2017-12-20       Impact factor: 4.096

3.  Molecular basis of Tousled-Like Kinase 2 activation.

Authors:  Gulnahar B Mortuza; Dario Hermida; Anna-Kathrine Pedersen; Sandra Segura-Bayona; Blanca López-Méndez; Pilar Redondo; Patrick Rüther; Irina Pozdnyakova; Ana M Garrote; Inés G Muñoz; Marina Villamor-Payà; Cristina Jauset; Jesper V Olsen; Travis H Stracker; Guillermo Montoya
Journal:  Nat Commun       Date:  2018-06-28       Impact factor: 14.919

4.  Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry.

Authors:  Bertrand Simon; Hua Jane Lou; Clotilde Huet-Calderwood; Guangda Shi; Titus J Boggon; Benjamin E Turk; David A Calderwood
Journal:  Nat Commun       Date:  2022-02-08       Impact factor: 14.919

5.  Differential Gene Expression in the Hippocampi of Nonhuman Primates Chronically Exposed to Methamphetamine, Cocaine, or Heroin.

Authors:  Mi Ran Choi; Yeung-Bae Jin; Han-Na Kim; Heejin Lee; Young Gyu Chai; Sang-Rae Lee; Dai-Jin Kim
Journal:  Psychiatry Investig       Date:  2022-07-21       Impact factor: 3.202

6.  High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancer.

Authors:  Siddhant Bhoir; Althaf Shaik; Vijay Thiruvenkatam; Sivapriya Kirubakaran
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

7.  De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.

Authors:  Margot R F Reijnders; Kerry A Miller; Mohsan Alvi; Jacqueline A C Goos; Melissa M Lees; Anna de Burca; Alex Henderson; Alison Kraus; Barbara Mikat; Bert B A de Vries; Bertrand Isidor; Bronwyn Kerr; Carlo Marcelis; Caroline Schluth-Bolard; Charu Deshpande; Claudia A L Ruivenkamp; Dagmar Wieczorek; Diana Baralle; Edward M Blair; Hartmut Engels; Hermann-Josef Lüdecke; Jacqueline Eason; Gijs W E Santen; Jill Clayton-Smith; Kate Chandler; Katrina Tatton-Brown; Katelyn Payne; Katherine Helbig; Kelly Radtke; Kimberly M Nugent; Kirsten Cremer; Tim M Strom; Lynne M Bird; Margje Sinnema; Maria Bitner-Glindzicz; Marieke F van Dooren; Marielle Alders; Marije Koopmans; Lauren Brick; Mariya Kozenko; Megan L Harline; Merel Klaassens; Michelle Steinraths; Nicola S Cooper; Patrick Edery; Patrick Yap; Paulien A Terhal; Peter J van der Spek; Phillis Lakeman; Rachel L Taylor; Rebecca O Littlejohn; Rolph Pfundt; Saadet Mercimek-Andrews; Alexander P A Stegmann; Sarina G Kant; Scott McLean; Shelagh Joss; Sigrid M A Swagemakers; Sofia Douzgou; Steven A Wall; Sébastien Küry; Eduardo Calpena; Nils Koelling; Simon J McGowan; Stephen R F Twigg; Irene M J Mathijssen; Christoffer Nellaker; Han G Brunner; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2018-05-31       Impact factor: 11.025

8.  Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors.

Authors:  Sung-Bau Lee; Sandra Segura-Bayona; Marina Villamor-Payà; Giulia Saredi; Matthew A M Todd; Camille Stephan-Otto Attolini; Ting-Yu Chang; Travis H Stracker; Anja Groth
Journal:  Sci Adv       Date:  2018-08-08       Impact factor: 14.136

9.  Knockdown of Tousled‑like kinase 1 inhibits survival of glioblastoma multiforme cells.

Authors:  Kamariah Ibrahim; Nor Azian Abdul Murad; Roslan Harun; Rahman Jamal
Journal:  Int J Mol Med       Date:  2020-05-28       Impact factor: 4.101

10.  Changes in chromatin accessibility landscape and histone H3 core acetylation during valproic acid-induced differentiation of embryonic stem cells.

Authors:  Claudia Baumann; Xiangyu Zhang; Ling Zhu; Yuhong Fan; Rabindranath De La Fuente
Journal:  Epigenetics Chromatin       Date:  2021-12-27       Impact factor: 4.954

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.